Figure 1From: Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer Cancer - specific survival rates according to neutrophil - lymphocyte ratio ( NLR ). The 5-year cancer-specific survival rates were 76.9% and 45.6% in patients with NLR < 3 and NLR ≥ 3, respectively (p = 0.01).Back to article page